PROTEC · 109MS408
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, open-label study assessing the effectiveness of oral Tecfidera™ (dimethyl fumarate) on multiple sclerosis disease activity and patient-reported outcomes in people with relapsing-remitting multiple sclerosis in clinical practice (PROTEC). EudraCT: 2013-001656-35.
Sponsor: BIOGEN
Phase: IV
Area: Neuroimmunology